Tyndall Capital Partners L P, 10% Owner at Onconova Therapeutics, Inc. (ONTX), sold 400 shares at $2.77 ($1K) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Open-market sale of $1k ONTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| ONTX | SELL | 2019-09-20 | $210K | — | Filing → |
| ONTX | SELL | 2019-09-13 | $3K | — | Filing → |
| ONTX | SELL | 2019-09-09 | $15K | — | Filing → |